Research Signal – Source date 2026-01-07
Concussion recovery is often judged through symptoms, but feeling better does not by itself show how the brain’s physiology is changing. Researchers are looking for ways to measure that biology alongside what teenagers report. A small study of adolescents with concussion found that a brain creatine measurement was associated with symptom severity and differed between female and male participants. The study offers a snapshot of those relationships, not a way to tell whether an individual teenager is recovering.
A scan measured one brain region about 12 days after injury
The study included adolescents aged 13 to 18 who were still experiencing concussion symptoms. They were assessed within three weeks of injury, at an average of about 12 days. Of 30 participants scanned, 27 had data of sufficient quality for analysis: 15 female and 12 male. They had been diagnosed and recruited through a sports medicine clinic, and participants were expected to return to organized sports after recovery.
Researchers used magnetic resonance spectroscopy, or MRS, to estimate the concentration of total creatine in the posterior cingulate gyrus, a region near the middle of the brain. The analysis counted creatine and phosphocreatine together. These molecules are involved in storing and making energy available in brain tissue, so total creatine can serve as an energy-related marker.
MRS estimates the amount of these chemicals in a selected volume of tissue. It does not directly measure how quickly the brain is using energy or whether energy supply is sufficient. The result was a concentration from one region at one point in time, collected alongside questionnaires about symptoms and everyday functioning.
Higher readings went with fewer reported difficulties
Within this group, adolescents with higher posterior cingulate creatine concentrations tended to report less severe concussion symptoms. The association with overall symptom severity was moderately strong (correlation r = −0.61). Higher concentrations were also associated with fewer reported mobility difficulties (r = −0.57) and less pain interference (r = −0.40).
The direction of the questionnaire scores matters: higher scores reflected worse symptoms, more trouble with mobility, or more interference from pain. The negative correlations therefore mean that higher creatine readings tended to occur alongside lower reported difficulties. They do not show that a higher reading caused symptoms to ease, or that a lower reading predicts a worse outcome for any one teenager.
The researchers also used models that adjusted for sex. The associations between creatine and the patient-reported domains remained in those models. They did not detect an interaction showing that the relationship between creatine and reported outcomes differed between female and male participants. With only 27 usable scans, however, the study had limited ability to identify more complex patterns.
The sex comparison describes this cohort, not a clinical threshold
Male participants had a higher average total creatine concentration than female participants: 12.9 versus 12.3 millimoles per liter. The difference was statistically significant in this sample. It is a comparison between the two groups as measured after concussion; the design cannot establish whether concussion produced the difference.
A pre-existing difference in brain chemistry could contribute, as could injury-related changes or other factors. The study had no non-injured comparison group to help separate those explanations. Researchers also did not find evidence that sex changed the relationship between symptom ratings and creatine. The observed group difference does not establish separate reference thresholds or different recovery guidance for teenagers.
Fatigue did not follow the same simple pattern
Fatigue is a useful example of why the results should be read outcome by outcome. The unadjusted correlation between creatine and fatigue was weak and was not statistically significant. In a model adjusting for sex, fatigue ratings were associated with creatine. These analyses answer related but different questions, and the result does not make the simple correlation stronger than it was.
The broader symptom pattern was not reproduced by every chemical measured. The paper also examined N-acetylaspartate and choline. Those metabolites did not show the same broad associations with symptom severity, fatigue, and pain. A separate association between N-acetylaspartate and mobility was reported, but the study’s findings do not support treating all measured brain chemicals as interchangeable indicators of recovery.
One time point cannot separate cause from consequence
Because the participants were scanned only once, the study cannot show whether creatine rose or fell as any teenager recovered. It also cannot tell whether a concentration measured around 12 days after injury predicts later symptoms or return to activity. The correlations could reflect creatine’s relationship to symptoms, symptoms’ relationship to factors that affect creatine, or influences shared by both.
The small, symptomatic sports-clinic cohort narrows what can be concluded. It does not represent every teenager with concussion, including those who were not still symptomatic at assessment or who were treated in other settings. Without uninjured participants measured in the same way, the researchers could not determine whether the sex difference was already present before injury or whether the observed concentrations were specific to concussion. Individual biology, prior health, injury characteristics, and other influences could also matter, but this study was not large enough to resolve them.
These constraints leave the central clinical question open: does brain creatine change in a meaningful way as an individual teenager recovers? Answering it would require repeated measurements over time and comparisons that can distinguish injury-related changes from baseline differences. The current data establish an association in a small group, not a recovery test or a treatment target.
What a brain energy marker might add to concussion care
If future studies show that repeated, validated brain chemistry measurements track physiological recovery after concussion, clinicians could eventually use them alongside teenagers’ symptom reports to build a fuller picture of recovery. That could help address a gap between how someone feels and how brain physiology is changing. The possibility depends on larger longitudinal research establishing which changes are specific to injury and how closely they relate to meaningful recovery; these findings alone are not ready to guide care.
Key Sources
- Primary source: Brain creatine concentrations are associated with sex and symptom severity after concussion: a cross-sectional MR-spectroscopy investigation of adolescents with concussion.
DOI or Journal Page · Peer-Reviewed Paper · 2026-01-07
Keep exploring